Lantern Pharma Inc (LTRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,229 | 1,232 | N/A | N/A | N/A |
| TOTAL | $20,237 | $1,233 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 22 | 9 | N/A | N/A | N/A |
| Other Non-Current Assets | 101 | 191 | 0 | 0 | 0 |
| TOTAL | $123 | $200 | $N/A | $N/A | $N/A |
| Total Assets | $20,360 | $1,433 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 552 | 489 | 0 | 0 | 0 |
| TOTAL | $552 | $489 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 109 | N/A | N/A | N/A | N/A |
| TOTAL | $109 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $661 | $489 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,170 | N/A | N/A | N/A | N/A |
| Common Shares | 1 | 0 | N/A | N/A | N/A |
| Retained earnings | -12,660 | -6,752 | N/A | N/A | N/A |
| TOTAL | $19,699 | $943 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $20,360 | $1,433 | $0 | $0 | $0 |